Report cover image

Global Blood Banking and Blood Products Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 217 Pages
SKU # APRC20279012

Description

Summary

According to APO Research, the global Blood Banking and Blood Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Blood Banking and Blood Products market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Blood Banking and Blood Products market include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Blood Banking and Blood Products, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Blood Banking and Blood Products, also provides the value of main regions and countries. Of the upcoming market potential for Blood Banking and Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Banking and Blood Products revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Blood Banking and Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Blood Banking and Blood Products company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Blood Banking and Blood Products Segment by Company


Red Cross Society of China

Yuanda Shuyang

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Vitalant

Takeda

Sanquin Blood Supply Foundation

Octapharma

NHS Blood and Transplant

New York Blood Center

National Blood Transfusion Council

LFB Group

KM Biologics

Kedrion

Japan Red Cross Society

Grifols

CSL

Canadian Blood Services

BPL

Blood Bank of Alaska

Biotest

Australia Red Cross

American Red Cross

America’s Blood Centers

Blood Banking and Blood Products Segment by Type


RBCs

Whole Blood

Plasma

Plasma Fractionation Products

Plts

Blood Banking and Blood Products Segment by Application


Clinic

Hospital

Retail Pharmacy

Others

Blood Banking and Blood Products Segment by Region


North America


United States

Canada

Mexico

Europe


Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific


China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America


Brazil

Argentina

Chile

Middle East & Africa


Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Banking and Blood Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Blood Banking and Blood Products key companies, revenue, market share, and recent developments.
3. To split the Blood Banking and Blood Products breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Blood Banking and Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Banking and Blood Products significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Banking and Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.
Chapter 3: Detailed analysis of Blood Banking and Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Blood Banking and Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Blood Banking and Blood Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

217 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Blood Banking and Blood Products Market Size, 2020 VS 2024 VS 2031
1.3 Global Blood Banking and Blood Products Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Blood Banking and Blood Products Market Dynamics
2.1 Blood Banking and Blood Products Industry Trends
2.2 Blood Banking and Blood Products Industry Drivers
2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
2.4 Blood Banking and Blood Products Industry Restraints
3 Blood Banking and Blood Products Market by Company
3.1 Global Blood Banking and Blood Products Company Revenue Ranking in 2024
3.2 Global Blood Banking and Blood Products Revenue by Company (2020-2025)
3.3 Global Blood Banking and Blood Products Company Ranking (2023-2025)
3.4 Global Blood Banking and Blood Products Company Manufacturing Base and Headquarters
3.5 Global Blood Banking and Blood Products Company Product Type and Application
3.6 Global Blood Banking and Blood Products Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Blood Banking and Blood Products Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Blood Banking and Blood Products Market by Type
4.1 Blood Banking and Blood Products Type Introduction
4.1.1 RBCs
4.1.2 Whole Blood
4.1.3 Plasma
4.1.4 Plasma Fractionation Products
4.1.5 Plts
4.2 Global Blood Banking and Blood Products Sales Value by Type
4.2.1 Global Blood Banking and Blood Products Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Blood Banking and Blood Products Sales Value by Type (2020-2031)
4.2.3 Global Blood Banking and Blood Products Sales Value Share by Type (2020-2031)
5 Blood Banking and Blood Products Market by Application
5.1 Blood Banking and Blood Products Application Introduction
5.1.1 Clinic
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 Global Blood Banking and Blood Products Sales Value by Application
5.2.1 Global Blood Banking and Blood Products Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Blood Banking and Blood Products Sales Value by Application (2020-2031)
5.2.3 Global Blood Banking and Blood Products Sales Value Share by Application (2020-2031)
6 Blood Banking and Blood Products Regional Value Analysis
6.1 Global Blood Banking and Blood Products Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Blood Banking and Blood Products Sales Value by Region (2020-2031)
6.2.1 Global Blood Banking and Blood Products Sales Value by Region: 2020-2025
6.2.2 Global Blood Banking and Blood Products Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Blood Banking and Blood Products Sales Value (2020-2031)
6.3.2 North America Blood Banking and Blood Products Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Blood Banking and Blood Products Sales Value (2020-2031)
6.4.2 Europe Blood Banking and Blood Products Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Blood Banking and Blood Products Sales Value (2020-2031)
6.5.2 Asia-Pacific Blood Banking and Blood Products Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Blood Banking and Blood Products Sales Value (2020-2031)
6.6.2 South America Blood Banking and Blood Products Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Blood Banking and Blood Products Sales Value (2020-2031)
6.7.2 Middle East & Africa Blood Banking and Blood Products Sales Value Share by Country, 2024 VS 2031
7 Blood Banking and Blood Products Country-level Value Analysis
7.1 Global Blood Banking and Blood Products Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Blood Banking and Blood Products Sales Value by Country (2020-2031)
7.2.1 Global Blood Banking and Blood Products Sales Value by Country (2020-2025)
7.2.2 Global Blood Banking and Blood Products Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.3.2 USA Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.4.2 Canada Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.6.2 Germany Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.7.2 France Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.7.3 France Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.9.2 Italy Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.10.2 Spain Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.11.2 Russia Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.14.2 China Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.14.3 China Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.15.2 Japan Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.17.2 India Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.17.3 India Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.18.2 Australia Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.22.2 Chile Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.24.2 Peru Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.26.2 Israel Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.27.2 UAE Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.29.2 Iran Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Blood Banking and Blood Products Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Blood Banking and Blood Products Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Blood Banking and Blood Products Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Red Cross Society of China
8.1.1 Red Cross Society of China Comapny Information
8.1.2 Red Cross Society of China Business Overview
8.1.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
8.1.5 Red Cross Society of China Recent Developments
8.2 Yuanda Shuyang
8.2.1 Yuanda Shuyang Comapny Information
8.2.2 Yuanda Shuyang Business Overview
8.2.3 Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
8.2.5 Yuanda Shuyang Recent Developments
8.3 Weiguang Bio
8.3.1 Weiguang Bio Comapny Information
8.3.2 Weiguang Bio Business Overview
8.3.3 Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
8.3.5 Weiguang Bio Recent Developments
8.4 Tiantan Bio
8.4.1 Tiantan Bio Comapny Information
8.4.2 Tiantan Bio Business Overview
8.4.3 Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
8.4.5 Tiantan Bio Recent Developments
8.5 CBPO
8.5.1 CBPO Comapny Information
8.5.2 CBPO Business Overview
8.5.3 CBPO Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.5.4 CBPO Blood Banking and Blood Products Product Portfolio
8.5.5 CBPO Recent Developments
8.6 Shuanglin Bio
8.6.1 Shuanglin Bio Comapny Information
8.6.2 Shuanglin Bio Business Overview
8.6.3 Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
8.6.5 Shuanglin Bio Recent Developments
8.7 RAAS
8.7.1 RAAS Comapny Information
8.7.2 RAAS Business Overview
8.7.3 RAAS Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.7.4 RAAS Blood Banking and Blood Products Product Portfolio
8.7.5 RAAS Recent Developments
8.8 Nanyue Bio
8.8.1 Nanyue Bio Comapny Information
8.8.2 Nanyue Bio Business Overview
8.8.3 Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
8.8.5 Nanyue Bio Recent Developments
8.9 Hualan Bio
8.9.1 Hualan Bio Comapny Information
8.9.2 Hualan Bio Business Overview
8.9.3 Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
8.9.5 Hualan Bio Recent Developments
8.10 Boya Bio
8.10.1 Boya Bio Comapny Information
8.10.2 Boya Bio Business Overview
8.10.3 Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
8.10.5 Boya Bio Recent Developments
8.11 Vitalant
8.11.1 Vitalant Comapny Information
8.11.2 Vitalant Business Overview
8.11.3 Vitalant Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
8.11.5 Vitalant Recent Developments
8.12 Takeda
8.12.1 Takeda Comapny Information
8.12.2 Takeda Business Overview
8.12.3 Takeda Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.12.4 Takeda Blood Banking and Blood Products Product Portfolio
8.12.5 Takeda Recent Developments
8.13 Sanquin Blood Supply Foundation
8.13.1 Sanquin Blood Supply Foundation Comapny Information
8.13.2 Sanquin Blood Supply Foundation Business Overview
8.13.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
8.13.5 Sanquin Blood Supply Foundation Recent Developments
8.14 Octapharma
8.14.1 Octapharma Comapny Information
8.14.2 Octapharma Business Overview
8.14.3 Octapharma Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
8.14.5 Octapharma Recent Developments
8.15 NHS Blood and Transplant
8.15.1 NHS Blood and Transplant Comapny Information
8.15.2 NHS Blood and Transplant Business Overview
8.15.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
8.15.5 NHS Blood and Transplant Recent Developments
8.16 New York Blood Center
8.16.1 New York Blood Center Comapny Information
8.16.2 New York Blood Center Business Overview
8.16.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
8.16.5 New York Blood Center Recent Developments
8.17 National Blood Transfusion Council
8.17.1 National Blood Transfusion Council Comapny Information
8.17.2 National Blood Transfusion Council Business Overview
8.17.3 National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
8.17.5 National Blood Transfusion Council Recent Developments
8.18 LFB Group
8.18.1 LFB Group Comapny Information
8.18.2 LFB Group Business Overview
8.18.3 LFB Group Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
8.18.5 LFB Group Recent Developments
8.19 KM Biologics
8.19.1 KM Biologics Comapny Information
8.19.2 KM Biologics Business Overview
8.19.3 KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
8.19.5 KM Biologics Recent Developments
8.20 Kedrion
8.20.1 Kedrion Comapny Information
8.20.2 Kedrion Business Overview
8.20.3 Kedrion Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
8.20.5 Kedrion Recent Developments
8.21 Japan Red Cross Society
8.21.1 Japan Red Cross Society Comapny Information
8.21.2 Japan Red Cross Society Business Overview
8.21.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
8.21.5 Japan Red Cross Society Recent Developments
8.22 Grifols
8.22.1 Grifols Comapny Information
8.22.2 Grifols Business Overview
8.22.3 Grifols Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.22.4 Grifols Blood Banking and Blood Products Product Portfolio
8.22.5 Grifols Recent Developments
8.23 CSL
8.23.1 CSL Comapny Information
8.23.2 CSL Business Overview
8.23.3 CSL Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.23.4 CSL Blood Banking and Blood Products Product Portfolio
8.23.5 CSL Recent Developments
8.24 Canadian Blood Services
8.24.1 Canadian Blood Services Comapny Information
8.24.2 Canadian Blood Services Business Overview
8.24.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
8.24.5 Canadian Blood Services Recent Developments
8.25 BPL
8.25.1 BPL Comapny Information
8.25.2 BPL Business Overview
8.25.3 BPL Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.25.4 BPL Blood Banking and Blood Products Product Portfolio
8.25.5 BPL Recent Developments
8.26 Blood Bank of Alaska
8.26.1 Blood Bank of Alaska Comapny Information
8.26.2 Blood Bank of Alaska Business Overview
8.26.3 Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
8.26.5 Blood Bank of Alaska Recent Developments
8.27 Biotest
8.27.1 Biotest Comapny Information
8.27.2 Biotest Business Overview
8.27.3 Biotest Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.27.4 Biotest Blood Banking and Blood Products Product Portfolio
8.27.5 Biotest Recent Developments
8.28 Australia Red Cross
8.28.1 Australia Red Cross Comapny Information
8.28.2 Australia Red Cross Business Overview
8.28.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
8.28.5 Australia Red Cross Recent Developments
8.29 American Red Cross
8.29.1 American Red Cross Comapny Information
8.29.2 American Red Cross Business Overview
8.29.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
8.29.5 American Red Cross Recent Developments
8.30 America’s Blood Centers
8.30.1 America’s Blood Centers Comapny Information
8.30.2 America’s Blood Centers Business Overview
8.30.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (2020-2025)
8.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
8.30.5 America’s Blood Centers Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.